[
  {
    "ts": null,
    "headline": "Genmab to acquire closely watched cancer drug in $8B Merus buyout",
    "summary": "The deal hands Genmab a drug that showed the potential in earlier testing to extend survival in head and neck cancer when added to Merck’s widely used immunotherapy Keytruda.",
    "url": "https://finnhub.io/api/news?id=5e33d88c6b66c715a4fbf239c4504f2466842091a46a72349de82ffe876b4f71",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759145280,
      "headline": "Genmab to acquire closely watched cancer drug in $8B Merus buyout",
      "id": 136915781,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "The deal hands Genmab a drug that showed the potential in earlier testing to extend survival in head and neck cancer when added to Merck’s widely used immunotherapy Keytruda.",
      "url": "https://finnhub.io/api/news?id=5e33d88c6b66c715a4fbf239c4504f2466842091a46a72349de82ffe876b4f71"
    }
  },
  {
    "ts": null,
    "headline": "Cheapest S&P 500 Stocks Ranked: 30 Best Value Buys",
    "summary": "Discover 30 top large-cap stocks offering strong value and quality.",
    "url": "https://finnhub.io/api/news?id=128fd721f9f6e5596b2df433e7890d99c8fbaabc25a5e6304c77ff2d7740de20",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759141719,
      "headline": "Cheapest S&P 500 Stocks Ranked: 30 Best Value Buys",
      "id": 136915123,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2189068007/image_2189068007.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "Discover 30 top large-cap stocks offering strong value and quality.",
      "url": "https://finnhub.io/api/news?id=128fd721f9f6e5596b2df433e7890d99c8fbaabc25a5e6304c77ff2d7740de20"
    }
  },
  {
    "ts": null,
    "headline": "Merck Selects Broadridge to Transform Treasury Operations with Real-Time Account Visibility",
    "summary": "Broadridge Financial Solutions, Inc. (NYSE: BR), a global Fintech leader, today announced that Merck has selected Broadridge to implement Swift's new Instant Cash Reporting service through its Swift Service Bureau (SSB) and SCORE+ services. The comprehensive solution enables Merck to transform treasury operations with real-time, on-demand access to balance and transaction information of more than 400 accounts globally.",
    "url": "https://finnhub.io/api/news?id=c0be3f2a9b958675c9a8e4cb2ccb48ca35b7125a9f97ec3049b19ee99b9df512",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759125600,
      "headline": "Merck Selects Broadridge to Transform Treasury Operations with Real-Time Account Visibility",
      "id": 136913666,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Broadridge Financial Solutions, Inc. (NYSE: BR), a global Fintech leader, today announced that Merck has selected Broadridge to implement Swift's new Instant Cash Reporting service through its Swift Service Bureau (SSB) and SCORE+ services. The comprehensive solution enables Merck to transform treasury operations with real-time, on-demand access to balance and transaction information of more than 400 accounts globally.",
      "url": "https://finnhub.io/api/news?id=c0be3f2a9b958675c9a8e4cb2ccb48ca35b7125a9f97ec3049b19ee99b9df512"
    }
  },
  {
    "ts": null,
    "headline": "Merck (MRK) Announces Positive Recommendation from EU Medicines Agency",
    "summary": "​Merck & Co., Inc. (NYSE:MRK) is one of the Most Undervalued Growth Stocks to Buy According to Hedge Funds. On September 19, Merck & Co., Inc. (NYSE:MRK) announced that its ENFLONSIA has received a positive recommendation from the European Medicines Agency’s Committee for Medicinal Products for Human Use. ​The approval is for preventing respiratory syncytial […]",
    "url": "https://finnhub.io/api/news?id=eaddf2ccac5d36c9f14c91089c4ecf8da5246e73a64ac3e024e6b5770bbbae25",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759124374,
      "headline": "Merck (MRK) Announces Positive Recommendation from EU Medicines Agency",
      "id": 136913667,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "​Merck & Co., Inc. (NYSE:MRK) is one of the Most Undervalued Growth Stocks to Buy According to Hedge Funds. On September 19, Merck & Co., Inc. (NYSE:MRK) announced that its ENFLONSIA has received a positive recommendation from the European Medicines Agency’s Committee for Medicinal Products for Human Use. ​The approval is for preventing respiratory syncytial […]",
      "url": "https://finnhub.io/api/news?id=eaddf2ccac5d36c9f14c91089c4ecf8da5246e73a64ac3e024e6b5770bbbae25"
    }
  },
  {
    "ts": null,
    "headline": "Rapid Micro Biosystems Inc. (RPID) Targeting 25%-30% Annual Revenue Growth Rate",
    "summary": "Rapid Micro Biosystems (NASDAQ:RPID) is one of the best performing penny stocks to buy now. On September 9, at the HC Wainwright 27th Annual Global Investment Conference, the company reaffirmed its commitment to innovation and automation as it seeks to replace traditional testing methods. Its GrowthDirect platform already offers automated, compliant testing solutions, expected to […]",
    "url": "https://finnhub.io/api/news?id=c4cb7b260744fe3d9a40b1f2c780b1d45811e14a72dced0263c18a37d8443987",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759121782,
      "headline": "Rapid Micro Biosystems Inc. (RPID) Targeting 25%-30% Annual Revenue Growth Rate",
      "id": 136913668,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Rapid Micro Biosystems (NASDAQ:RPID) is one of the best performing penny stocks to buy now. On September 9, at the HC Wainwright 27th Annual Global Investment Conference, the company reaffirmed its commitment to innovation and automation as it seeks to replace traditional testing methods. Its GrowthDirect platform already offers automated, compliant testing solutions, expected to […]",
      "url": "https://finnhub.io/api/news?id=c4cb7b260744fe3d9a40b1f2c780b1d45811e14a72dced0263c18a37d8443987"
    }
  },
  {
    "ts": null,
    "headline": "1 Surging  Stock Worth Your Attention and 2 We Avoid",
    "summary": "Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over the last month as catalysts such as new products and positive media coverage have propelled their returns.",
    "url": "https://finnhub.io/api/news?id=d12456c2bed59a3737262f9ba362566b8b616867cd87d396cb2528f3cd091e12",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759120794,
      "headline": "1 Surging  Stock Worth Your Attention and 2 We Avoid",
      "id": 136913669,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over the last month as catalysts such as new products and positive media coverage have propelled their returns.",
      "url": "https://finnhub.io/api/news?id=d12456c2bed59a3737262f9ba362566b8b616867cd87d396cb2528f3cd091e12"
    }
  }
]